Stopping the Pharmaceutical Industry from Keeping drugs Expensive Act or the SPIKE Act
This bill requires the Centers for Medicare & Medicaid Services (CMS) to determine at least annually whether certain covered drugs under Medicare were subject to a price increase that exceeded specified thresholds. Drug manufacturers must submit justifications for such price increases to the CMS, subject to civil penalties. The bill's requirements do not apply to low-cost drugs, as identified by the CMS.
| Action Date | Type | Text | Source |
|---|---|---|---|
| 2019-05-21 | Committee | Subcommittee Hearings Held. | House committee actions |
| 2019-04-04 | Committee | Referred to the Subcommittee on Health. | House committee actions |
| 2019-04-03 | Committee | Referred to the Subcommittee on Health. | House committee actions |
| 2019-04-03 | IntroReferral | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. | House floor actions |
| 2019-04-03 | IntroReferral | Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. | House floor actions |
| 2019-04-03 | IntroReferral | Introduced in House | Library of Congress |